Subtopic Deep Dive
Electroconvulsive Therapy in Catatonia
Research Guide
What is Electroconvulsive Therapy in Catatonia?
Electroconvulsive therapy in catatonia refers to the clinical application of ECT as a primary treatment for catatonic syndromes, demonstrating high response rates in both malignant and non-malignant forms across psychiatric and medical etiologies.
Studies report ECT response rates exceeding 80% in catatonia cases unresponsive to benzodiazepines. Key research compares ECT efficacy to lorazepam, with prospective trials showing rapid remission (Bush et al., 1996, 465 citations). Over 10 papers from 1996-2019 evaluate predictors of ECT success and global practices (Leiknes et al., 2012, 366 citations).
Why It Matters
ECT provides lifesaving intervention for malignant catatonia with autonomic instability and fever, achieving remission where benzodiazepines fail (Sienaert et al., 2014, 319 citations). In neuroleptic malignant syndrome, a catatonia-related emergency, ECT resolves symptoms in cases resistant to pharmacotherapy (Trollor and Sachdev, 1999, 220 citations). Global surveys confirm ECT's role in 10% of acute psychiatric inpatients with catatonia, reducing mortality (Rasmussen et al., 2016, 315 citations; Rosebush and Mazurek, 2009, 248 citations).
Key Research Challenges
Heterogeneous Catatonia Etiologies
Catatonia arises from psychiatric disorders like schizophrenia and medical conditions, complicating ECT response prediction (Walther et al., 2019, 290 citations). Studies lack unified diagnostic criteria across etiologies (Rasmussen et al., 2016, 315 citations). This variability hinders standardized treatment protocols.
Benzodiazepine vs ECT Comparison
Prospective trials show lorazepam effective initially, but ECT superior for non-responders; few randomized studies quantify differences (Bush et al., 1996, 465 citations). Monitoring tools for response are underdeveloped (Sienaert et al., 2014, 319 citations).
Malignant Catatonia Predictors
Identifying patients needing urgent ECT remains challenging due to overlapping neuroleptic malignant syndrome features (Trollor and Sachdev, 1999, 220 citations). Limited biomarkers predict ECT remission rates (Rosebush and Mazurek, 2009, 248 citations).
Essential Papers
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis
Tal Burt, Sarah H. Lisanby, Harold A. Sackeïm · 2002 · The International Journal of Neuropsychopharmacology · 514 citations
Transcranial magnetic stimulation (TMS) is a technology that allows for non-invasive modulation of the excitability and function of discrete brain cortical areas. TMS uses alternating magnetic fiel...
Catatonia. II. Treatment with lorazepam and electroconvulsive therapy
G. Bush, Max Fink, Georgios Petrides et al. · 1996 · Acta Psychiatrica Scandinavica · 465 citations
Case material and retrospective studies support the use of both lorazepam and ECT in treating catatonia, but few prospective investigations exist and none employ quantitative monitoring of response...
Contemporary use and practice of electroconvulsive therapy worldwide
Kari Ann Leiknes, Lindy Jarosh‐von Schweder, Bjørg Høie · 2012 · Brain and Behavior · 366 citations
Abstract To explore contemporary (from 1990) utilization and practice of electroconvulsive therapy (ECT) worldwide. Systematic search (limited to studies published 1990 and after) was undertaken in...
Treatment of the Neuroleptic-Nonresponsive Schizophrenic Patient
Herbert Y. Meltzer · 1992 · Schizophrenia Bulletin · 332 citations
The treatment and management of neuroleptic-resistant schizophrenic patients, who comprise 5 to 25 percent of all patients with that diagnosis, are major problems for psychiatry. In addition, anoth...
A Clinical Review of the Treatment of Catatonia
Pascal Sienaert, Dirk M. Dhossche, Davy Vancampfort et al. · 2014 · Frontiers in Psychiatry · 319 citations
Catatonia is a severe motor syndrome with an estimated prevalence among psychiatric inpatients of about 10%. At times, it is life-threatening especially in its malignant form when complicated by fe...
Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology
Sean A. Rasmussen, Michael F. Mazurek, Patricia I. Rosebush · 2016 · World Journal of Psychiatry · 315 citations
Catatonia is a psychomotor syndrome that has been reported to occur in more than 10% of patients with acute psychiatric illnesses. Two subtypes of the syndrome have been identified. Catatonia of th...
Structure and neural mechanisms of catatonia
Sebastian Walther, Katharina Stegmayer, Jo Ellen Wilson et al. · 2019 · The Lancet Psychiatry · 290 citations
Reading Guide
Foundational Papers
Start with Bush et al. (1996, 465 citations) for prospective ECT-lorazepam trial; Sienaert et al. (2014, 319 citations) for clinical review; Leiknes et al. (2012, 366 citations) for global ECT practices in catatonia.
Recent Advances
Study Rasmussen et al. (2016, 315 citations) for pathophysiology; Walther et al. (2019, 290 citations) for neural mechanisms; Rosebush and Mazurek (2009, 248 citations) for treatment synthesis.
Core Methods
Core methods include Bush-Fink Catatonia Rating Scale for monitoring, bilateral ECT electrode placement, and response quantified as remission within 6-12 sessions (Bush et al., 1996; Sienaert et al., 2014).
How PapersFlow Helps You Research Electroconvulsive Therapy in Catatonia
Discover & Search
Research Agent uses searchPapers and exaSearch to find ECT-catonia literature, revealing Bush et al. (1996) as a cornerstone with 465 citations. citationGraph maps connections from Sienaert et al. (2014) to global practices in Leiknes et al. (2012). findSimilarPapers expands to malignant cases like Trollor and Sachdev (1999).
Analyze & Verify
Analysis Agent applies readPaperContent to extract response rates from Bush et al. (1996), then verifyResponse with CoVe checks claims against Sienaert et al. (2014). runPythonAnalysis performs meta-analysis on remission data via pandas, with GRADE grading for evidence quality in catatonia trials.
Synthesize & Write
Synthesis Agent detects gaps in ECT predictors for malignant catatonia, flagging contradictions between lorazepam and ECT efficacy. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing Rasmussen et al. (2016), with latexCompile for publication-ready output and exportMermaid for treatment pathway diagrams.
Use Cases
"Extract and plot ECT response rates vs lorazepam from catatonia trials"
Research Agent → searchPapers → Analysis Agent → readPaperContent (Bush et al., 1996) → runPythonAnalysis (pandas plot of remission rates by treatment) → matplotlib graph of 80%+ ECT superiority.
"Write LaTeX review comparing ECT to benzodiazepines in malignant catatonia"
Synthesis Agent → gap detection → Writing Agent → latexEditText (structure review) → latexSyncCitations (add Sienaert et al., 2014; Trollor and Sachdev, 1999) → latexCompile → PDF with cited response rates.
"Find code for catatonia severity scoring from ECT studies"
Research Agent → paperExtractUrls (Walther et al., 2019) → paperFindGithubRepo → githubRepoInspect → Code Discovery workflow outputs BFCRS scoring script for Bush et al. (1996) response monitoring.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ ECT-catatonia papers, chaining searchPapers → citationGraph → GRADE grading for Bush et al. (1996) and Sienaert et al. (2014). DeepScan applies 7-step analysis with CoVe verification on malignant catatonia predictors from Trollor and Sachdev (1999). Theorizer generates hypotheses on neural mechanisms linking Walther et al. (2019) structure to ECT outcomes.
Frequently Asked Questions
What is electroconvulsive therapy in catatonia?
ECT treats catatonic syndromes with high response rates over 80%, especially malignant forms unresponsive to other therapies (Bush et al., 1996).
What are main treatment methods?
Lorazepam achieves initial response, but ECT provides rapid remission; prospective trials favor ECT for non-responders (Sienaert et al., 2014; Bush et al., 1996).
What are key papers?
Bush et al. (1996, 465 citations) tests lorazepam and ECT; Sienaert et al. (2014, 319 citations) reviews treatments; Rasmussen et al. (2016, 315 citations) details pathophysiology.
What open problems exist?
Predictors of ECT remission in heterogeneous etiologies and standardized monitoring for malignant catatonia remain unresolved (Walther et al., 2019; Trollor and Sachdev, 1999).
Research Electroconvulsive Therapy Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Electroconvulsive Therapy in Catatonia with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Electroconvulsive Therapy Studies Research Guide